Matrix Metalloproteinase 9 Level Changes in the Gingival Crevicular Fluid Samples of Teeth with Symptomatic and Asymptomatic Irreversible Pulpitis: A Prospective Cohort Study MMP-9 Level Changes in Acute and Chronic Apical Periodontitis
Regeneration, Reconstruction & Restoration (Triple R),
Vol. 9 (2024),
1 January 2024
https://doi.org/10.22037/rrr.v9.45670
Abstract
Background and objectives: This article delve into the valuable insights provided by molecular markers, particularly Matrix Metalloproteinase 9 (MMP-9), in the context of pulpal diagnosis. It emphasizes the challenges associated with current diagnostic tools and advocates for enhanced methods to ensure a reliable diagnosis. Elevated MMP-9 levels emerge as potential biomarkers not only for pulpal diseases but also for periodontal and cardiovascular conditions. The exploration extends to molecular alterations and diagnostic biomarkers in gingival crevicular fluid, shedding light on promising avenues for dental diagnosis and customized treatment approaches.
Materials and methods: Gingival crevicular fluid (GCF) samples were collected from 56 eligible patients using medium-sized paper points. A second set of GCF samples was collected two weeks post- root canal treatment. Normal samples were obtained from patients referred for routine dental check-ups. GCF samples were transferred to sampling tubes with Tris HCL pH = 7.5 buffer. MMP-9 levels were measured using ELISA.
Results: Statistical analysis revealed a significant decrease in MMP-9 levels in GCF after root canal treatment for both symptomatic and asymptomatic irreversible pulpitis (P-value < 0.05). The study identifies an increase in MMP-9 during pulp inflammation. Subsequently, MMP-9 levels decrease in the gingival crevicular fluid after root canal treatment, indicating the resolution of inflammation.
Conclusion: Precision in evaluating and measuring enzymes associated with pulp tissue destruction in the local gingival crevicular fluid is achievable through a precise method. The examination of MMP-9 in gingival crevicular fluid can serve as a valuable tool for monitoring inflammatory activity and assessing the success of treating teeth with symptomatic and asymptomatic irreversible pulpitis.
- Gingival crevicular fluid
- Matrix metalloproteinase 9
- Pulpitis
- root canal therapy
How to Cite
References
Cushley S, Duncan HF, Lappin MJ, Tomson PL, Lundy FT, Cooper P, et al. Pulpotomy for mature carious teeth with symptoms of irreversible pulpitis: a systematic review. J Dent. 2019;88:103158.
Dahlkemper P. American Association of Endodontists: Guide to clinical endodontics. Chicago, USA; 2016.
Lin LM, Ricucci D, Saoud TM, Sigurdsson A, Kahler B. Vital pulp therapy of mature permanent teeth with irreversible pulpitis from the perspective of pulp biology. Australian Endodontic Journal. 2020;46(1):154-66.
Dolińska E, Pietruska M, Dymicka-Piekarska V, Milewski R, Sculean A. Matrix Metalloproteinase 9 (MMP-9) and Interleukin-8 (IL-8) in Gingival Crevicular Fluid after Regenerative Therapy in Periodontal Intrabony Defects with and without Systemic Antibiotics—Randomized Clinical Trial. Pathogens. 2022;11(10):1184.
Bonadio A, Oguche S, Lavy T, Kleifeld O, Shifman J. Computational design of Matrix Metalloproteinase-9 (MMP-9) resistant to auto-cleavage. Biochemical Journal. 2023;480(14):1097-107.
Sharma R, Kumar V, Logani A, Chawla A, Mir R, Sharma S, et al. Association between concentration of active MMP‐9 in pulpal blood and pulpotomy outcome in permanent mature teeth with irreversible pulpitis–a preliminary study. Int Endod J. 2021;54(4):479-89.
Augoff K, Hryniewicz-Jankowska A, Tabola R, Stach K. MMP9: A Tough Target for Targeted Therapy for Cancer. Cancers. 2022;14(7).
Zehnder M, Wegehaupt FJ, Attin T. A first study on the usefulness of matrix metalloproteinase 9 from dentinal fluid to indicate pulp inflammation. J Endod. 2011;37(1):17-20.
Isola G, Polizzi A, Ronsivalle V, Alibrandi A, Palazzo G, Lo Giudice A. Impact of matrix metalloproteinase-9 during periodontitis and cardiovascular diseases. mol. 2021;26(6):1777.
Söder B, Airila Månsson S, Söder PÖ, Kari K, Meurman J. Levels of matrix metalloproteinases‐8 and‐9 with simultaneous presence of periodontal pathogens in gingival crevicular fluid as well as matrix metalloproteinase‐9 and cholesterol in blood. Journal of periodontal research. 2006;41(5):411-7.
Menezes-Silva R, Khaliq S, Deeley K, Letra A, Vieira AR. Genetic susceptibility to periapical disease: conditional contribution of MMP2 and MMP3 genes to the development of periapical lesions and healing response. J Endod. 2012;38(5):604-7.
Wahlgren J, Salo T, Teronen O, Luoto H, Sorsa T, Tjäderhane L. Matrix metalloproteinase-8 (MMP-8) in pulpal and periapical inflammation and periapical root-canal exudates. Int Endod J. 2002;35(11):897-904.
Zhang H, Liu L, Jiang C, Pan K, Deng J, Wan C. MMP9 protects against LPS-induced inflammation in osteoblasts. Innate immunity. 2020;26(4):259-69.
Gusman H, Santana RB, Zehnder M. Matrix metalloproteinase levels and gelatinolytic activity in clinically healthy and inflamed human dental pulps. Eur J Oral Sci. 2002;110(5):353-7.
Gür B, Afacan B, Çevik Ö, Köse T, Emingil G. Gingival crevicular fluid periodontal ligament‐associated protein‐1, sclerostin, and tumor necrosis factor‐alpha levels in periodontitis. J Periodontol. 2023;94(10):1166-75.
Zehnder M, Belibasakis GN. A critical analysis of research methods to study clinical molecular biomarkers in Endodontic research. Int Endod J. 2022;55:37-45.
Shin S-J, Lee W, Lee J-I, Baek S-H, Kum K-Y, Shon W-J, et al. Matrix metalloproteinase-8 and substance P levels in gingival crevicular fluid during endodontic treatment of painful, nonvital teeth. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112(4):548-54.
Mente J, Petrovic J, Gehrig H, Rampf S, Michel A, Schürz A, et al. A prospective clinical pilot study on the level of matrix metalloproteinase-9 in dental pulpal blood as a marker for the state of inflammation in the pulp tissue. J Endod. 2016;42(2):190-7.
Ahmed GM, El-Baz AA, Hashem AAR, Shalaan AK. Expression levels of matrix metalloproteinase-9 and gram-negative bacteria in symptomatic and asymptomatic periapical lesions. J Endod. 2013;39(4):444-8.
Accorsi-Mendonça T, Silva EJNL, Marcaccini AM, Gerlach RF, Duarte KMR, Pardo APS, et al. Evaluation of gelatinases, tissue inhibitor of matrix metalloproteinase-2, and myeloperoxidase protein in healthy and inflamed human dental pulp tissue. J Endod. 2013;39(7):879-82.
Heidari A, Shahrabi M, Shahrabi MS, Ghandehari M, Rahbar P. Comparison of the level of substance P and neurokinin A in gingival crevicular fluid of sound and symptomatic carious primary teeth by ELISA. J Dent (Tehran). 2017;14(4):173.
Avellan N-L, Sorsa T, Tervahartiala T, Mäntylä P, Forster C, Kemppainen P. Painful tooth stimulation elevates matrix metalloproteinase-8 levels locally in human gingival crevicular fluid. J Dent Res. 2005;84(4):335-9.
Dincer GA, Erdemir A, Kisa U. Comparison of neurokinin A, substance P, interleukin 8, and matrix metalloproteinase-8 changes in pulp tissue and gingival crevicular fluid samples of healthy and symptomatic irreversible pulpitis teeth. J Endod. 2020;46(10):1428-37.
Dincer G, Erdemir A, Kisa U. Comparison of NKA, SP, IL-8, MMP-8 changes in pulp tissue and GCF samples of healthy and acute irreversible pulpitis teeth. J Endod. 2020;46:1428-37.
Zanini M, Meyer E, Simon S. Pulp inflammation diagnosis from clinical to inflammatory mediators: a systematic review. J Endod. 2017;43(7):1033-51.
Zhou S, Xu J. Downregulation of microRNA‑204 increases the expression of matrix metallopeptidase 9 in pediatric patients with pulpitis and Helicobacter pylori infection in the stomach. Experimental and Therapeutic Medicine. 2019;18(1):253-9.
Chen M, Zeng J, Yang Y, Wu B. Diagnostic biomarker candidates for pulpitis revealed by bioinformatics analysis of merged microarray gene expression datasets. BMC Oral Health. 2020;20:1-13.
- Abstract Viewed: 260 times
- PDF Downloaded: 80 times